Log in to save to my catalogue

Myrtenol complexed with β‐cyclodextrin ameliorates behavioural deficits and reduces oxidative stress...

Myrtenol complexed with β‐cyclodextrin ameliorates behavioural deficits and reduces oxidative stress...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2558455952

Myrtenol complexed with β‐cyclodextrin ameliorates behavioural deficits and reduces oxidative stress in the reserpine‐induced animal model of Parkinsonism

About this item

Full title

Myrtenol complexed with β‐cyclodextrin ameliorates behavioural deficits and reduces oxidative stress in the reserpine‐induced animal model of Parkinsonism

Publisher

Australia: Wiley Subscription Services, Inc

Journal title

Clinical and experimental pharmacology & physiology, 2021-11, Vol.48 (11), p.1488-1499

Language

English

Formats

Publication information

Publisher

Australia: Wiley Subscription Services, Inc

More information

Scope and Contents

Contents

Current pharmacological approaches to treat Parkinson’s disease have low long‐term efficacy and important adverse side effects. The development of new pharmacological therapies has focused on novel plant‐derived phytochemicals. The alcoholic monoterpene myrtenol has been isolated from several plant species, and has anxiolytic, analgesic, anti‐infla...

Alternative Titles

Full title

Myrtenol complexed with β‐cyclodextrin ameliorates behavioural deficits and reduces oxidative stress in the reserpine‐induced animal model of Parkinsonism

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2558455952

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2558455952

Other Identifiers

ISSN

0305-1870,1440-1681

E-ISSN

1440-1681

DOI

10.1111/1440-1681.13563

How to access this item